Endpoints News· @endpts · X·· 2 小时前精选AI 评分78
AI 导读
Endpoints News报道，礼来的amylin与Zepbound联合疗法在肥胖合并糖尿病患者中取得有史以来最佳的减重效果。该结果在EASD26会议上公布，具体数据见链接。
正文
⚡️Breaking: Lilly's amylin-Zepbound combo breaks a weight loss record https://endpoints.news/easd26-lillys-amylin-zepbound-combo-posts-best-ever-weight-loss-in-patients-with-obesity-and-diabetes/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
来源：Endpoints News · x.com